Efficacy of selpercatinib after prior systemic therapy in patients with RET mutant medullary thyroid cancer Meeting Abstract


Authors: Wirth, L. J.; Sherman, E. J.; Weiler, D.; Cabanillas, M. E.; Robinson, B.; Italiano, A.; Laskin, J. J.; Subbiah, V.; Drilon, A. E.; Soldatenkova, V.; French, P. P.; Wright, J.; Kroiss, M.; Shah, M. H.
Abstract Title: Efficacy of selpercatinib after prior systemic therapy in patients with RET mutant medullary thyroid cancer
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120603265
DOI: 10.1200/JCO.2021.39.15_suppl.6074
PROVIDER: wos
Notes: Meeting Abstract: 6074 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eric J Sherman
    339 Sherman
  2. Alexander Edward Drilon
    632 Drilon